{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:10:18Z","timestamp":1793279418760,"version":"4.5.0"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Despite access to routine laboratory evaluation, primary hyperparathyroidism (PHP) remains underdiagnosed and undertreated.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To determine the consequences associated with missed diagnoses and prolonged time to diagnosis and treatment of PHP.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This is a retrospective cohort study of patients older than 40 years with 2 instances of hypercalcemia during 2010 to 2020 and 3 years of follow-up. Patients were recruited from 63 health care organizations in the TriNetX Research Network. Data analysis was performed from January 2010 to September 2020.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Elevated serum calcium.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Existing symptoms and diagnoses associated with PHP (osteoporosis, fractures, urolithiasis, major depressive disorder, anxiety, hypertension, gastroesophageal reflux disease, malaise or fatigue, joint pain or myalgias, constipation, insomnia, polyuria, weakness, abdominal pain, headache, nausea, amnesia, and gallstones) compared in patients deemed high-risk and without a diagnosis and matched controls, and those who experienced times from documented hypercalcemia to diagnosis and diagnosis to treatment within or beyond 1 year.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n There were 135\u202f034 patients analyzed (96\u202f554 women [72%]; 28\u202f892 Black patients [21%] and 88\u202f010 White patients [65%]; 3608 Hispanic patients [3%] and 98\u202f279 non-Hispanic patients [73%]; mean [SD] age, 63 [10] years). Two groups without a documented diagnosis of PHP were identified as high risk: 20\u202f176 patients (14.9%) with parathyroid hormone greater than or equal to 50 pg\/mL and 24\u202f905 patients (18.4%) with no parathyroid hormone level obtained or recorded explanation for hypercalcemia. High-risk patients experienced significantly increased rates of all associated symptoms and diagnoses compared with matched controls. Just 9.7% of those with hypercalcemia (13\u202f136 patients) had a diagnosis of PHP. Compared with individuals who received a diagnosis within 1 year of hypercalcemia, those whose workup exceeded 1 year had significantly increased rates of major depressive disorder, anxiety, hypertension, gastroesophageal reflux disease, malaise or fatigue, joint pain or myalgias, polyuria, weakness, abdominal pain, and headache at 3 years. The rate of osteoporosis increased from 17.1% (628 patients) to 25.4% (935 patients) over the study period in the group with delayed diagnosis. Among those with a diagnosis, 5280 patients (40.2%) underwent parathyroidectomy. Surgery beyond 1 year of diagnosis was associated with significantly increased rates of osteoporosis and hypertension at 3 years after diagnosis compared with those treated within 1 year.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n Many patients were at high risk for PHP without a documented diagnosis. Complications in these patients, as well as those who received a diagnosis after prolonged workup or time to treatment, resulted in patient harm. System-level interventions are necessary to ensure proper diagnosis and prompt treatment of PHP.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.48332","type":"journal-article","created":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T11:00:42Z","timestamp":1672138842000},"page":"e2248332","source":"Crossref","is-referenced-by-count":34,"title":["Analysis of Time to Diagnosis and Outcomes Among Adults With Primary Hyperparathyroidism"],"prefix":"10.1001","volume":"5","author":[{"given":"F. Jeffrey","family":"Lorenz","sequence":"first","affiliation":[{"name":"College of Medicine, The Pennsylvania State University, Hershey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Beauchamp-Perez","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Penn State Hershey Medical Center, Hershey, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Manni","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, Department of Medicine, Penn State Hershey Medical Center, Hershey, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Penn State Hershey Medical Center, Hershey, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goldenberg","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Penn State Hershey Medical Center, Hershey, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neerav","family":"Goyal","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Penn State Hershey Medical Center, Hershey, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,12,27]]},"reference":[{"issue":"10116","key":"zoi221368r1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","article-title":"Hyperparathyroidism.","volume":"391","author":"Bilezikian","year":"2018","journal-title":"Lancet"},{"issue":"10","key":"zoi221368r2","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.amjmed.2010.12.028","article-title":"Outpatient management of primary hyperparathyroidism.","volume":"124","author":"Padmanabhan","year":"2011","journal-title":"Am J Med"},{"issue":"9","key":"zoi221368r3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.mpsur.2011.06.015","article-title":"Hyperparathyroidism.","volume":"29","author":"Gopinath","year":"2011","journal-title":"Surgery"},{"issue":"5","key":"zoi221368r4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.reuma.2011.06.001","article-title":"Hyperparathyroidism: primary or secondary disease?","volume":"8","author":"Cordellat","journal-title":"Rheumatol Clin"},{"issue":"1","key":"zoi221368r5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jss.2006.02.029","article-title":"A prospective evaluation of novel methods to intraoperatively distinguish parathyroid tissue utilizing a parathyroid hormone assay.","volume":"133","author":"Conrad","year":"2006","journal-title":"J Surg Res"},{"issue":"1","key":"zoi221368r6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.5152\/UCD.","article-title":"Primary hyperparathyroidism.","volume":"32","author":"Madkhali","year":"2016","journal-title":"Ulus Cerrahi Derg"},{"issue":"1","key":"zoi221368r7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.amjsurg.2019.10.010","article-title":"Rates of hypercalcemia and hyperparathyroidism among patients with porcelain gallbladder.","volume":"220","author":"Berger","year":"2020","journal-title":"Am J Surg"},{"issue":"10","key":"zoi221368r8","doi-asserted-by":"publisher","first-page":"e336","DOI":"10.1093\/bjs\/znab249","article-title":"Association of symptomatic gallstones and primary hyperparathyroidism: a propensity score-matched analysis.","volume":"108","author":"Saito","year":"2021","journal-title":"Br J Surg"},{"issue":"8","key":"zoi221368r9","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1002\/hed.v38.8","article-title":"Impact of parathyroidectomy for primary hyperparathyroidism on quality of life: a case-control study using Short Form Health Survey 36.","volume":"38","author":"Dulfer","year":"2016","journal-title":"Head Neck"},{"issue":"1","key":"zoi221368r10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.21037\/gs","article-title":"Primary hyperparathyroidism and hypertension.","volume":"9","author":"Fisher","year":"2020","journal-title":"Gland Surg"},{"issue":"10","key":"zoi221368r11","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism.","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"issue":"3","key":"zoi221368r12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/lary.v128.3","article-title":"Early neurocognitive improvements following parathyroidectomy for primary hyperparathyroidism.","volume":"128","author":"Shah-Becker","year":"2018","journal-title":"Laryngoscope"},{"issue":"4","key":"zoi221368r13","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/lio2.v5.4","article-title":"Investigating the potential underdiagnosis of primary hyperparathyroidism at the University of Arkansas for Medical Sciences.","volume":"5","author":"Quilao","year":"2020","journal-title":"Laryngoscope Investig Otolaryngol"},{"issue":"9","key":"zoi221368r14","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1007\/s00268-018-4574-1","article-title":"Primary hyperparathyroidism is underdiagnosed and suboptimally treated in the clinical setting.","volume":"42","author":"Enell","year":"2018","journal-title":"World J Surg"},{"issue":"6","key":"zoi221368r15","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.surg.2013.06.051","article-title":"The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record.","volume":"154","author":"Press","year":"2013","journal-title":"Surgery"},{"key":"zoi221368r16","doi-asserted-by":"publisher","DOI":"10.1177\/1179551418815916","article-title":"Why is hyperparathyroidism underdiagnosed and undertreated in older adults?","volume":"11","author":"Dombrowsky","year":"2018","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"issue":"4","key":"zoi221368r17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1308\/003588411X13020175704352","article-title":"Primary hyperparathyroidism: how many cases are being missed?","volume":"93","author":"Shapey","year":"2011","journal-title":"Ann R Coll Surg Engl"},{"issue":"4","key":"zoi221368r18","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/SLA.0000000000002370","article-title":"Failure to diagnose hyperparathyroidism in 10,432 patients with hypercalcemia: opportunities for system-level intervention to increase surgical referrals and cure.","volume":"266","author":"Balentine","year":"2017","journal-title":"Ann Surg"},{"issue":"9","key":"zoi221368r19","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1001\/jamainternmed.2019.1747","article-title":"Diagnosis and management of primary hyperparathyroidism across the Veterans Affairs health care system.","volume":"179","author":"Alore","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"24","key":"zoi221368r25","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1001\/jama.2014.9195","article-title":"Parathyroid hormone in the evaluation of hypercalcemia.","volume":"312","author":"Cusano","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"zoi221368r26","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1210\/jcem-71-2-370","article-title":"Rate and concentration dependence of parathyroid hormone dynamics during stepwise changes in serum ionized calcium in normal humans.","volume":"71","author":"Grant","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"zoi221368r27","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1210\/jc.2012-2499","article-title":"Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study.","volume":"98","author":"Rejnmark","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"zoi221368r28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.7861\/clinmedicine.13-3-287","article-title":"How to approach hypercalcaemia.","volume":"13","author":"Crowley","year":"2013","journal-title":"Clin Med (Lond)"},{"issue":"1","key":"zoi221368r30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jocd.2012.11.005","article-title":"Asymptomatic primary hyperparathyroidism.","volume":"16","author":"Silverberg","year":"2013","journal-title":"J Clin Densitom"},{"key":"zoi221368r31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4158\/EP10311.RA","article-title":"Cost-effectiveness of parathyroidectomy for primary hyperparathyroidism.","volume":"17","author":"Zanocco","year":"2011","journal-title":"Endocr Pract"},{"issue":"6","key":"zoi221368r32","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S0039-6060(99)70224-2","article-title":"Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels.","volume":"125","author":"Burney","year":"1999","journal-title":"Surgery"},{"issue":"7","key":"zoi221368r33","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00423-010-0689-z","article-title":"Persistent symptomatic improvement in the majority of patients undergoing parathyroidectomy for primary hyperparathyroidism.","volume":"395","author":"Gopinath","year":"2010","journal-title":"Langenbecks Arch Surg"},{"issue":"4","key":"zoi221368r34","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/ndt\/gfy054","article-title":"Hypercalcemia: etiology and management.","volume":"33","author":"Renaghan","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"zoi221368r35","doi-asserted-by":"publisher","first-page":"e828","DOI":"10.1634\/theoncologist.2018-0424","article-title":"Failure to diagnose and treat hyperparathyroidism among patients with hypercalcemia: opportunities for intervention at the patient and physician level to increase surgical referral.","volume":"24","author":"Asban","year":"2019","journal-title":"Oncologist"},{"issue":"3","key":"zoi221368r36","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jamcollsurg.2011.06.401","article-title":"Can biochemical abnormalities predict symptomatology in patients with primary hyperparathyroidism?","volume":"213","author":"Bargren","year":"2011","journal-title":"J Am Coll Surg"},{"key":"zoi221368r21","first-page":"115","volume-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"Portale","year":"1999","edition":"4th ed"},{"key":"zoi221368r22","volume-title":"Clinical Methods: The History, Physical, and Laboratory Examinations","author":"Goldstein","year":"1990","edition":"3rd ed"},{"key":"zoi221368r20","unstructured":"TriNetX Analytics Network. Accessed November 16, 2022. https:\/\/trinetx.com"},{"key":"zoi221368r23","doi-asserted-by":"crossref","unstructured":"Shane? E. Etiology of hypercalcemia. UptoDate. 2021. Accessed November 16, 2022. https:\/\/www.uptodate.com\/contents\/etiology-of-hypercalcemia","DOI":"10.1097\/01.COT.0000911056.28044.c7"},{"key":"zoi221368r24","unstructured":"Horwitz? M. Hypercalcemia of malignancy: mechanisms. UptoDate. 2020. Accessed November 16, 2022. https:\/\/www.uptodate.com\/contents\/hypercalcemia-of-malignancy-mechanisms"},{"key":"zoi221368r29","unstructured":"Vakiti? A, Mewawalla? P. Malignancy-related hypercalcemia. January 2022. Accessed November 16, 2022. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29494030"},{"key":"zoi221368r37","unstructured":"US Census Bureau. Age and sex composition in the United States: 2019. October 8, 2021. Accessed November 16, 2022. https:\/\/www.census.gov\/data\/tables\/2019\/demo\/age-and-sex\/2019-age-sex-composition.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2799946\/lorenz_2022_oi_221368_1671208882.35755.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T03:17:12Z","timestamp":1679195832000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2799946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,27]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.48332","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,27]]}}}